Prostate Cancer
A Phase 1 Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of AMG 509 in Subjects With Metastatic Castration-Resistant Prostate Cancer (20180146)
- Details
ClinicalTrials.gov ID:
NCT04221542
Diagnosis Type:
NA
USOR Number:
- Address
,
P: